Home NDC 0185-0674 hydroxyzine pamoate
Product NDC 0185-0674
11-digit product format 001850674
Labeler code 0185
Product ID 0185-0674_c94e4245-cac4-4d59-b3a3-64a09b67c2e9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name hydroxyzine pamoate
Dosage form CAPSULE
Route ORAL
Labeler Sandoz Inc
Application ANDA087479
Marketing category ANDA
Marketing start 1981-12-14
Substance HYDROXYZINE PAMOATE
Active strength 25 mg/1
Pharmacologic classes Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A087479-001 HYDROXYZINE PAMOATE HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A087479-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 84e616aacf4f…2026-08-18 06:07:40 2026-07 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A087479-001 HYDROXYZINE PAMOATE EQ 25MG HYDROCHLORIDE CAPSULE / ORAL AB Approved before 1982 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base hydroxyzine pamoate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength HYDROXYZINE PAMOATE 25 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination M20215MUFR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 995253 Internal RxNorm lookup 995278 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0185-0674-01 hydroxyzine pamoate 100 in 1 BOTTLE CAPSULE 100 36 0185-0674-05 hydroxyzine pamoate 500 in 1 BOTTLE CAPSULE 500 36 0185-0674-10 hydroxyzine pamoate 1000 in 1 BOTTLE CAPSULE 1000 36
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYDROXYZINE PAMOATE ACTIVE INGREDIENT M20215MUFR HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 HYDROXYZINE ACTIVE MOIETY 30S50YM8OG HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 GELATIN INACTIVE INGREDIENT 2G86QN327L HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 SHELLAC INACTIVE INGREDIENT 46N107B71O HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP HYDROXYZINE PAMOATE CAPSULE [EON LABS, INC.] 20 HYDROXYZINE PAMOATE ACTIVE INGREDIENT M20215MUFR HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 HYDROXYZINE ACTIVE MOIETY 30S50YM8OG HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 GELATIN INACTIVE INGREDIENT 2G86QN327L HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP HYDROXYZINE PAMOATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] 17 HYDROXYZINE PAMOATE ACTIVE INGREDIENT M20215MUFR HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 HYDROXYZINE ACTIVE MOIETY 30S50YM8OG HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP HYDROXYZINE PAMOATE CAPSULE [CLINICAL SOLUTIONS WHOLSESALE] 2 HYDROXYZINE PAMOATE ACTIVE INGREDIENT M20215MUFR HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 HYDROXYZINE PAMOATE ACTIVE INGREDIENT M20215MUFR HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 HYDROXYZINE ACTIVE MOIETY 30S50YM8OG HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 HYDROXYZINE ACTIVE MOIETY 30S50YM8OG HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 SHELLAC INACTIVE INGREDIENT 46N107B71O HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP HYDROXYZINE PAMOATE CAPSULE [AMERICAN HEALTH PACKAGING] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP HYDROXYZINE PAMOATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0185-0674 HYDROXYZINE PAMOATE CAPSULE HYDROXYZINE PAMOATE CAPSULE HYDROXYZINE PAMOATE CAPSULE [SANDOZ INC] 36 Current NDC, Legacy NDC, 3 package rows 20240320_c38cfd32-2562-4d6c-8a2e-d9984c16d9eb.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 21 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0185-0674-01 00185067401 100 CAPSULE in 1 BOTTLE (0185-0674-01) 100 capsule 2014-06-27 0000-00-00 No No Current 0185-0674-05 00185067405 500 CAPSULE in 1 BOTTLE (0185-0674-05) 500 capsule 2014-06-27 0000-00-00 No No Current 0185-0674-10 00185067410 1000 CAPSULE in 1 BOTTLE (0185-0674-10) 1000 capsule 2014-06-27 0000-00-00 No No Current